|
|
Think You've Got Compliance Covered? Don't Count On It.
|
|
"Former President Bill Clinton… was
prescribed a statin for high cholesterol when he left
office. But he stopped taking it at some point. And at
age 58, he had to have quadruple bypass surgery
because of severely clogged arteries that doctors
said put him in danger of a heart attack."
Associated Press, 9/26/06
What's going on here? How is it possible that Bill
Clinton, an intelligent man with few economic
constraints and a host of people with an enormous
investment in his ongoing good health, could fall into
noncompliance?
It's a good question, and one that would seem to
poke a hole in the popular notion that noncompliance
is the result of economic hardship, lack of physician
concern, or patient incompetence. Indeed, Mr.
Clinton's experience is by no means the exception.
According to an article in the November 2006 issue
of PharmaVOICE, 15–25% of patients
never fill
the
prescription, 30–40% fill it only once, and a
staggering 50% of patients discontinue therapy
entirely by month six!
The old standbys are not enough.
Helping patients adhere to a treatment regimen
— whether that involves filling a prescription,
staying on a diet or exercise program, modifying
environmental factors, or some combination of all
— is easier said than done. And it's not for
lack of trying… it's simply because the people
and tactics we've turned to up until this point are not
enough:
- The doctor can't ensure compliance. I
love my doctor. He spends time with me and works
hard to explain how, when and how often any
medication he prescribes should work, including
letting me know about possible side effects. But he
was hard to find and is unique, and I know that our
mutual connection as industry insiders buys me more
of his time and attention than the average patient.
Physicians have enormous influence (good or
bad), but they generally don't have the time or energy
that's necessary to explain the disease, the
medication, the ramifications, the side effects and the
other factors necessary to build the foundations of a
good, compliant patient. Like a priest or rabbi who
doesn't call when you stop coming to services (even
if he welcomes you with open arms when you return),
today's doctors don't have the bandwidth to keep
track of patients when they leave the office.
- The patient can't ensure compliance.
Unfortunately, human nature works against
compliance. We're all creatures of habit, and even
with pharmacy reminders and similar external
prompts, once someone has made the decision
(consciously or not) to stop taking a given
medication, it's extremely difficult to bring them back
into the compliance zone. Shockingly, even
patients with life-threatening conditions such as
HIV/AIDS, cancer and diabetes stop taking their
medication in large numbers.
- DTC can't ensure compliance. Here as
well, mass market advertising has not demonstrated
an ability to move the compliance needle. Yes,
awareness of particular drugs and conditions may
cause someone to recognize a need and request a
prescription. But DTC is aimed almost entirely at
the start of the prescription-writing process; it
does
little to help a patient stay within a treatment
regimen.
What's the solution?
The approaches used to date don't work, plain
and simple. We can keep on doing the same,
watching market share and patient health steadily
erode, or we can take a different tack. Specifically,
programs need to be developed which include:
- Early patient contact. Once the patient
leaves the doctor's office the clock is ticking. Clearly,
preventing non-compliance is much more
manageable than trying to fix noncompliant patients
after the fact. Effective programs reach out to
patients quickly.
- Frequent patient contact. Every day
represents a new opportunity for a given patient to
fall off treatment. One time, one way information
transfer is not enough. Effective programs are
interactive, and remain in contact with the patient
over the duration of the treatment regimen.
- Automated feedback to the physician.
Programs which give physicians insight into patient
understanding and compliance — particularly
if done on an individual patient basis — allow
the doctor to monitor her effectiveness in keeping the
patient on treatment. A correct diagnosis and
prescription is of no use if treatment is not followed,
and doctors need an automated feedback loop
which lets them know whether or not what they've
recommended is working. Effective programs
provide useful information, and take the burden of
check-in off the doctor's calendar.
Lack of compliance hurts all of us… as
patients, as pharmaceutical professionals and as
citizens who in the end shoulder the burden of
mounting healthcare costs. The challenge is to
develop new ways and new approaches which help
patients (from former presidents on down) receive the
often readily available solutions they so desperately
need.
To share this bulletin with a friend or colleague, click here.
|
Lighting the Fuse… Practical Insights for Getting Results
by Dr. Stanley Wulf, M.D.
Compliance Management… Not All
Patients Are Created Equal
It's often useful to speak of compliance in macro
terms (e.g. "50% of patients discontinue therapy
entirely by month six."). In practice, however, all
that matters to the individual patient is his or
her own results.
Traditionally, these individual results have been
measured "after the fact," with patients being asked,
"Did you take your medicine as instructed?"
Unfortunately, because this information is
inherently retrospective, it's of no value to the patient
in question.
Much more beneficial, is to engage the patient in a
conversation at baseline — before any
treatment has begun.
Using as few as four key questions — all
supported by the literature as being highly predictive,
and all focused on how the patient has behaved in
prior treatment situations — we are able to
establish a Treatment Adherence Predictor (TAP); a
measure of how well a given patient will comply with
a treatment regimen.
Patients can then be reliably classified into three
levels of risk (high, medium, low), and supplied
information based on their individual TAP. So, for
example, those who are low risk, receive information
which supports their good, past behavior. As we
move up the risk scale on the other hand, we give
more attention, and gently, but firmly, include
information regarding the consequences of
noncompliance (e.g. morbidity and the impact on
quality of life), and even specific snippets of support
(e.g. "Keep your pills next to your toothbrush to help
remember.").
Why does it matter? Because "one size fits
nobody" treatment programs are in danger of offering
too little information to some, too much information to
others, and the perfect amount of the wrong
information to still others. The more we can
customize the experience before the fact, the
better we'll be at helping patients stay compliant.
|
Shameless Self-Promotion
|
|
InfoMedics was thrilled to be the Gold Sponsor of
this year's Patient Education and Disease
Awareness Summit, held for two days earlier this
week in Pennsylvania. Our own Paul Le Vine
(Vice President, Analytic Services) served as
Conference Co-Chair, and Dr. Stanley Wulf (Vice
President and Chief Medical Officer) delivered a
presentation on building market share and increasing
brand loyalty.
Some of the other critical topics covered in this
in-depth and interactive event were, "Patient-Centric
Marketing — The New Alternative to DTC,"
"Motivating Healthy Behavior with 360 Degree
Educational Programs," and "New Technologies Link
Patients, Physicians and Brands."
It was a great opportunity to share stories and
tactics,
make new friends and meet old ones, and refocus
our collective energies for the coming year.
Thanks to
those of you who attended!
|
|
|
Will The Doctor See You Now?
|
|
"The patients can spend as long as they need on the
phone talking to someone who can answer all of their
questions in these [InfoMedics] programs . I don't
have that kind of time to spend with them."
— Doctor of Internal Medicine, InfoMedics
Research, Fall, 2006
|
About Us
|
|
InfoMedics creates an interactive, real-time means
for helping patients and physicians better
communicate about a diagnosed condition or
prescribed treatment.
This results in
improved health
outcomes and consistent increases in prescribing
levels for new prescriptions and refills.
|
Case Study: Cholesterol Management and Medication Compliance in Cardiovascular Health
|
|
|